Skip to main content
FDMT logo
FDMT
(NASDAQ)
4D Molecular Therapeutics, Inc.
$9.48-- (--)
Loading... - Market loading

4D Molecular Therapeutics, Inc. (FDMT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for 4D Molecular Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Strong Buy
Based on 5 unique analysts
Medium Confidence:1 Buy/Sell

Average Price Target

$30.20
218.57% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest FDMT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Faisal Khurshid
Jefferies
Strong BuyInitiates
$40.00 $21.00
Matthew Caufield
HC Wainwright
Strong BuyReiterates
$36.00 $36.00
Geulah Livshits
Chardan Capital
Strong BuyMaintains
$26.00 $26.00
Lisa Walter
RBC Capital
BuyMaintains
$32.00 $35.00
Eliana Merle
Barclays
BuyInitiates
$33.00

Frequently Asked Questions

What is the analyst consensus rating for FDMT?

The analyst consensus rating for FDMT is "Strong Buy" based on 5 analyst recommendations.

What is the average price target for FDMT?

The average 12-month price target for FDMT is $30.20, representing an upside of 218.6% from the current price of $9.48.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.